$PRSO
Peraso Inc. Stock $prso

$prso Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023039800 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$2.403M	$5.033M
YoY Change	-43.91%	47.9%
Cost Of Revenue	$1.795M	$3.106M
YoY Change	-35.87%	59.45%
Gross Profit	$608.0K	$1.927M
YoY Change	-59.06%	32.44%
Gross Profit Margin	25.3%	38.29%
Selling, General & Admin	$1.977M	$2.242M
YoY Change	-31.31%	-17.12%
% of Gross Profit	325.16%	116.35%
Research & Development	$3.668M	$3.887M
YoY Change	-35.0%	-29.15%
% of Gross Profit	603.29%	201.71%
Depreciation & Amortization	$958.0K	$755.0K
YoY Change	25.39%	-2.71%
% of Gross Profit	157.57%	39.18%
Operating Expenses	$5.645M	$5.723M
YoY Change	-33.75%	-30.13%
Operating Profit	-$5.037M	-$3.796M
YoY Change	-28.41%	-43.65%
Interest Expense		$658.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$951.0K	-$10.00K
YoY Change	-95200.0%	-44.44%
Pretax Income	-$4.086M	-$3.148M
YoY Change	-41.98%	-53.39%
Income Tax
% Of Pretax Income
Net Earnings	-$4.086M	-$3.148M
YoY Change	-41.98%	-53.39%
Net Earnings / Revenue	-170.04%	-62.55%
Basic Earnings Per Share	-$0.17	-$0.15
Diluted Earnings Per Share	-$0.17	-$0.15
COMMON SHARES
Basic Shares Outstanding	15.73M shares	14.27M shares
Diluted Shares Outstanding	24.34M shares	21.56M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.740M	$1.392M
YoY Change	-44.24%	-85.77%
Cash & Equivalents	$2.146M	$805.0K
Short-Term Investments	$594.0K	$587.0K
Other Short-Term Assets	$729.0K	$742.0K
YoY Change	-49.59%	-44.34%
Inventory	$5.160M	$4.853M
Prepaid Expenses
Receivables	$1.497M	$2.881M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$10.13M	$9.868M
YoY Change	-32.68%	-47.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.850M	$2.078M
YoY Change	-9.62%	-26.1%
Goodwill
YoY Change
Intangibles	$5.031M	$5.754M
YoY Change	-31.34%
Long-Term Investments
YoY Change
Other Assets	$123.0K	$122.0K
YoY Change	-19.08%	56.41%
Total Long-Term Assets	$7.824M	$8.940M
YoY Change	-64.29%	-61.28%
TOTAL ASSETS
Total Short-Term Assets	$10.13M	$9.868M
Total Long-Term Assets	$7.824M	$8.940M
Total Assets	$17.95M	$18.81M
YoY Change	-51.42%	-55.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.142M	$1.364M
YoY Change	-52.12%	-29.73%
Accrued Expenses	$1.625M	$1.945M
YoY Change	-8.61%	-30.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.942M	$3.553M
YoY Change	-42.86%	-30.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.967M	$1.825M
YoY Change	449.45%	344.04%
Total Long-Term Liabilities	$3.967M	$1.825M
YoY Change	449.45%	344.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.942M	$3.553M
Total Long-Term Liabilities	$3.967M	$1.825M
Total Liabilities	$6.909M	$5.378M
YoY Change	17.68%	-2.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$156.8M	-$152.7M
YoY Change	19.72%
Common Stock	$22.00K	$15.00K
YoY Change	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.04M	$13.43M
YoY Change
Total Liabilities & Shareholders Equity	$17.95M	$18.81M
YoY Change	-51.42%	-55.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$4.086M	-$3.148M
YoY Change	-41.98%	-53.39%
Depreciation, Depletion And Amortization	$958.0K	$755.0K
YoY Change	25.39%	-2.71%
Cash From Operating Activities	-$2.160M	-$1.414M
YoY Change	-62.9%	-75.37%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$84.00K
YoY Change	-102.62%	10.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$500.0K
YoY Change	-100.0%	-86.64%
Cash From Investing Activities	-$7.000K	$416.0K
YoY Change	-100.14%	-88.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.508M	-$25.00K
YoY Change	-4715.79%	177.78%
NET CHANGE
Cash From Operating Activities	-2.160M	-$1.414M
Cash From Investing Activities	-7.000K	$416.0K
Cash From Financing Activities	3.508M	-$25.00K
Net Change In Cash	1.341M	-$1.023M
YoY Change	-238.11%	-51.33%
FREE CASH FLOW
Cash From Operating Activities	-$2.160M	-$1.414M
Capital Expenditures	$7.000K	$84.00K
Free Cash Flow	-$2.167M	-$1.498M
YoY Change	-60.99%	-74.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-32929
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0291941
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2309 Bering Drive
CY2023Q1	us-gaap	Liabilities Liabilities	5378000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7229000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95131
CY2023Q1	dei	City Area Code CityAreaCode	(408)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	418-7500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	PRSO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15730175	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	805000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1828000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	587000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1078000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2881000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3244000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4853000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5348000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	600000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	742000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	615000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9868000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12713000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2078000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2225000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5754000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6278000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	986000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1147000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	122000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	123000	usd
CY2023Q1	us-gaap	Assets Assets	18808000	usd
CY2022Q4	us-gaap	Assets Assets	22486000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1364000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1844000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1366000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1817000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	244000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	332000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	579000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	687000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3553000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4680000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	404000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	470000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1421000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2079000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3134000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6791000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14580000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14580000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14270000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14270000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	15000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	8797000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9107000	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	166171000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164865000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152745000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149597000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	13430000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15257000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18808000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22486000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5033000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3403000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3106000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1948000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1927000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1455000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3887000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5486000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2242000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2705000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	406000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5723000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	8191000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3796000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6736000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-658000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-10000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3148000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6754000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	14000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-37000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21561000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19769000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15257000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1307000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3148000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	13430000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	42069000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-9000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1171000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-37000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6754000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	36440000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3148000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6754000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	755000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	776000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1307000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1171000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-658000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-183000	usd
CY2023Q1	prso	Accrued Interest On Investments AccruedInterestOnInvestments	-6000	usd
CY2022Q1	prso	Accrued Interest On Investments AccruedInterestOnInvestments	22000	usd
CY2023Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	5000	usd
CY2022Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	130000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-546000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-331000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-495000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	698000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-474000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	192000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-480000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	165000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	121000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-147000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-107000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-539000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-544000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1414000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5740000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	500000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4240000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	497000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	416000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3647000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	25000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1023000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2102000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1828000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5893000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	805000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3791000	usd
CY2022Q1	prso	Recognition Of Rightofuse Assets And Lease Liabilities RecognitionOfRightofuseAssetsAndLeaseLiabilities	274000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-14000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	37000	usd
CY2021Q3	prso	Agreement Amount AgreementAmount	2864555000	shares
CY2023Q1	us-gaap	Net Investment In Lease Allowance For Credit Loss NetInvestmentInLeaseAllowanceForCreditLoss	3100000	usd
CY2022Q4	us-gaap	Net Investment In Lease Allowance For Credit Loss NetInvestmentInLeaseAllowanceForCreditLoss	32400000	usd
CY2023Q1	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	152700000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-size: 10pt"> </span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-size: 10pt">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period. Material estimates may include assumptions made in determining reserves for uncollectible receivables, inventory write-downs, impairment of long-term assets, purchase price allocations, valuation allowance on deferred tax assets, accruals for potential liabilities and assumptions made in valuing equity instruments. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><i> </i></b></span></p>
CY2023Q1	prso	Allowance For Doubtful Accounts As Percentage Of Invoice Value For Problematic Customer Balances Maximum AllowanceForDoubtfulAccountsAsPercentageOfInvoiceValueForProblematicCustomerBalancesMaximum	1	pure
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	183000000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	361000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	114000000	usd
CY2023Q1	prso	Tax Credit Percentage TaxCreditPercentage	0.15	pure
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8468000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2714000	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	5754000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8468000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2190000	usd
CY2022Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	6278000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	7000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1575000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2099000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2011000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	28000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	31000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5754000	usd
CY2022	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically 60 days or less.
CY2022Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1100000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	88000000	usd
CY2023Q1	prso	Revenue Practical Expedient Period In Which Customer Payments Due From Invoice Date RevenuePracticalExpedientPeriodInWhichCustomerPaymentsDueFromInvoiceDate	P60Y
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9309000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3569000	shares
CY2023Q1	prso	Corporate Notes And Commercial Paper CorporateNotesAndCommercialPaper	587000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1421000	usd
CY2022Q4	prso	Corporate Notes And Commercial Paper CorporateNotesAndCommercialPaper	1078000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2079000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1378000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	14000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1392000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2931000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2906000	usd
CY2023Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1	pure
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Maximum Contractual Term1 DeferredCompensationArrangementWithIndividualMaximumContractualTerm1	P5Y4M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.14	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1568000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1279000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1228000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2595000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2057000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1474000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4853000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5348000	usd
CY2023Q1	us-gaap	Incentive To Lessee IncentiveToLessee	220000000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1000000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.08	pure
CY2022Q1	prso	Lease Liability LeaseLiability	274000000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	124000000	usd
CY2022Q4	prso	Lease Liability LeaseLiability	117000000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	696000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	290000	usd
CY2023Q1	prso	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	986000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	692000	usd
CY2023Q1	prso	Finance Lease Liabilities FinanceLeaseLiabilities	291000	usd
CY2023Q1	prso	Operating And Financing Lease Liabilities OperatingAndFinancingLeaseLiabilities	983000	usd
CY2023Q1	prso	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	477000	usd
CY2023Q1	prso	Percentage Of Voting Power PercentageOfVotingPower	0.10	pure
CY2023Q1	prso	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	263000	usd
CY2023Q1	prso	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	164000	usd
CY2023Q1	prso	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	107000	usd
CY2023Q1	prso	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears	81000	usd
CY2023Q1	prso	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	1092000	usd
CY2023Q1	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	109000	usd
CY2023Q1	prso	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	983000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	199000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	129000	usd
CY2023Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	200000	usd
CY2022Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	100000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5033000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3403000	usd
CY2023Q1	prso	Product Category ProductCategory	4888000	usd
CY2022Q1	prso	Product Category ProductCategory	3204000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2023Q1	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.10	pure
CY2023Q1	prso	Accounts Receiveble Percentage AccountsReceiveblePercentage	0.77	pure
CY2022	prso	Accounts Receiveble Percentage AccountsReceiveblePercentage	0.79	pure
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1100000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	6600000	usd
CY2023Q1	prso	Share Based Compensation Arrangement By Share Based Payment Award Term Of Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfPlan	P1Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1556000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1499000	shares
CY2022Q4	prso	Weighted Average Exercise Prices Balance WeightedAverageExercisePricesBalance	3.32
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	80000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	51000	shares
CY2023Q1	prso	Number Of Shares Options Cancelled NumberOfSharesOptionsCancelled	-17000	shares
CY2023Q1	prso	Weighted Average Exercise Prices Options Cancelled WeightedAverageExercisePricesOptionsCancelled	6.76
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1527000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1482000	shares
CY2023Q1	prso	Weighted Average Exercise Prices Balance WeightedAverageExercisePricesBalance	3.28
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1057000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.06
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	80000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.99
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	51000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.07
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1086000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.98
CY2023Q1	prso	Exchangeable Percentage ExchangeablePercentage	0.10	pure
CY2023Q1	prso	Voting Power Percentage VotingPowerPercentage	0.50	pure
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	33000000	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	46700000	usd
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	3062500000	usd
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	437500000	usd
CY2022	prso	Gain On Transaction GainOnTransaction	2600000	usd
CY2023Q1	prso	Gain On Transaction GainOnTransaction	400000	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Peraso Inc.
CY2022Q4	prso	Preferred Stock Value One PreferredStockValueOne		usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19769000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities		usd
CY2023Q1	prso	Recognition Of Rightofuse Assets And Lease Liabilities RecognitionOfRightofuseAssetsAndLeaseLiabilities		usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax		usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax		usd
CY2023Q1	prso	Number Of Shares Rs Us Grantedin Dollars Per Share NumberOfSharesRSUsGrantedinDollarsPerShare		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
CY2023Q1	prso	Number Of Shares Rs Us Cancelled And Returned To The Plansin Dollars Per Share NumberOfSharesRSUsCancelledAndReturnedToThePlansinDollarsPerShare		shares
CY2023Q1	prso	Weighted Average Exercise Prices Rs Us Cancelled And Returned To The Plansin Dollars Per Share WeightedAverageExercisePricesRSUsCancelledAndReturnedToThePlansinDollarsPerShare
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000890394

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
prso-20230331_cal.xml	Edgar Link	unprocessable
prso-20230331_lab.xml	Edgar Link	unprocessable
0001213900-23-039800-index-headers.html	Edgar Link	pending
0001213900-23-039800-index.html	Edgar Link	pending
0001213900-23-039800.txt	Edgar Link	pending
0001213900-23-039800-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_perasoinc.htm	Edgar Link	pending
f10q0323ex31-2_perasoinc.htm	Edgar Link	pending
f10q0323ex32-1_perasoinc.htm	Edgar Link	pending
f10q0323_perasoinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prso-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
prso-20230331_def.xml	Edgar Link	unprocessable
prso-20230331_pre.xml	Edgar Link	unprocessable
f10q0323_perasoinc_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRSO
Peraso Inc. Stock $prso

2023 Q2 Form 10-Q Financial Statement

#000121390023039800 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSO Peraso Inc. Stock $prso

2023 Q2 Form 10-Q Financial Statement

#000121390023039800 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRSO
Peraso Inc. Stock $prso